1. Home
  2. SPT vs DNA Comparison

SPT vs DNA Comparison

Compare SPT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPT

Sprout Social Inc

HOLD

Current Price

$11.35

Market Cap

633.9M

Sector

Technology

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$8.11

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPT
DNA
Founded
2010
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
633.9M
562.3M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SPT
DNA
Price
$11.35
$8.11
Analyst Decision
Buy
Strong Sell
Analyst Count
10
1
Target Price
$26.00
$9.00
AVG Volume (30 Days)
1.1M
1.0M
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$443,750,000.00
$180,606,000.00
Revenue This Year
$13.30
N/A
Revenue Next Year
$11.37
$7.28
P/E Ratio
N/A
N/A
Revenue Growth
13.09
N/A
52 Week Low
$9.16
$5.00
52 Week High
$35.18
$17.58

Technical Indicators

Market Signals
Indicator
SPT
DNA
Relative Strength Index (RSI) 60.16 35.56
Support Level $10.50 $8.17
Resistance Level $11.47 $8.90
Average True Range (ATR) 0.48 0.59
MACD 0.11 -0.00
Stochastic Oscillator 66.16 1.01

Price Performance

Historical Comparison
SPT
DNA

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: